Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática

Published:2013-08 Issue:8 Volume:49 Page:343-353
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:es
Short-container-title:Archivos de Bronconeumología

Author:

Xaubet Antoni,Ancochea Julio,Bollo Elena,Fernández-Fabrellas Estrella,Franquet Tomás,Molina-Molina Maria,Montero Maria Angeles,Serrano-Mollar Anna

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference80 articles.

1. Idiopathic pulmonary fibrosis: Diagnosis and treatment; joint statement of the American Thoracic Society and the European Respiratory Society;Am J Respir Crit Care Med,2000

2. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

3. Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas;Xaubet;Arch Bronconeumol,2003

4. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations;Schünemann;Am J Respir Crit Care Med,2006

5. Incidence and prevalence of idiopathic pulmonary fibrosis;Raghu;Am J Respir Crit Care Med,2006

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study);BMC Pulmonary Medicine;2024-07-31

2. No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants;Clinical and Translational Science;2024-01

3. Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases;Respiratory Research;2023-12-18

4. Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;BMC Pulmonary Medicine;2023-11-29

5. Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study);PharmacoEconomics;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3